Baker Brothers Life Sciences LP, Director, 10% Owner at SEATTLE GENETICS INC /WA (SGEN), sold 1,750,000 shares at $160.00 ($280.0M) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Open-market sale of $280.0M SGEN by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.00 | 147,688 | $23.6M | 8.4% |
| 2 | $160.00 | 1,602,312 | $256.4M | 91.6% |
| Total | $160.00 avg | 1,750,000 | $280.0M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |